Amyloid-beta 40 as a biomarker of cognitive impairment in acute ischemic stroke
Aim: to study the role of amyloid-beta 40 (Aβ 40) in the development of cognitive impairment in acute ischemic stroke.Materials and methods. The study included 70 patients aged 33–86 years, 46 men and 24 women. In patients with acute ischemic stroke cognitive status was assessed with Mini-Mental Sta...
Saved in:
| Main Authors: | Aleksey A. Kulesh, Viktor E. Drobakha, Elena M. Kuklina, Vladimir V. Shestakov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2017-10-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/958 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted Magnetic Nanoparticles for Beta-Amyloid Detection
by: Nelly S. Chmelyuk, et al.
Published: (2024-10-01) -
Ursolic acid attenuates beta-amyloid-induced memory impairment in mice
by: Wenna Liang, et al.
Published: (2016-06-01) -
Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife
by: Minos Kritikos, et al.
Published: (2022-12-01) -
Potential biofluid markers for cognitive impairment in Parkinson’s disease
by: Jieyu Chen, et al.
Published: (2026-01-01) -
Klotho overexpression protects human cortical neurons from β-amyloid induced neuronal toxicity
by: Mohammed R. Shaker, et al.
Published: (2025-03-01)